Iqvia Holdings (IQV) Other Non-Current Liabilities (2012 - 2026)
Iqvia Holdings' (IQV) quarterly Other Non-Current Liabilities came in at $645.0 million in Q2 2026, down 3.87% year-over-year from $671.0 million in Q2 2025, and up 4.54% quarter-over-quarter from $617.0 million in Q1 2026.
Analysis
Iqvia Holdings (IQV) Other Non-Current Liabilities (2012 - 2026) Analysis & Trends
Iqvia Holdings has disclosed Other Non-Current Liabilities across 15 years of filings, most recently posting $645.0 million for Q2 2026.
- In Q2 2026, Other Non-Current Liabilities fell 3.87% year-over-year to $645.0 million; the TTM figure through Jun 2026 stood at $645.0 million (down 3.87% YoY), while the FY2025 annual figure was $688.0 million, up 2.99% from the prior year.
- Other Non-Current Liabilities came in at $645.0 million for Q2 2026 at Iqvia Holdings, up from $617.0 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $703.0 million in Q2 2023 to a low of $561.0 million in Q3 2022.
- Average Other Non-Current Liabilities over 5 years is $644.4 million, with a median of $656.5 million recorded in 2024.
- Year-over-year, Other Non-Current Liabilities dropped 14.48% in 2022 and advanced 24.87% in 2023.
- Over 5 years, Other Non-Current Liabilities stood at $671.0 million in 2022, then increased by 4.02% to $698.0 million in 2023, then decreased by 4.3% to $668.0 million in 2024, then advanced by 2.99% to $688.0 million in 2025, then decreased by 6.25% to $645.0 million in 2026.
- Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $645.0 million in Q2 2026, $617.0 million in Q1 2026, and $688.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 645.00 Mn |
| Mar 31, 2026 | 617.00 Mn |
| Dec 31, 2025 | 688.00 Mn |
| Sep 30, 2025 | 698.00 Mn |
| Jun 30, 2025 | 671.00 Mn |
| Mar 31, 2025 | 676.00 Mn |
| Dec 31, 2024 | 668.00 Mn |
| Sep 30, 2024 | 612.00 Mn |
| Jun 30, 2024 | 632.00 Mn |
| Mar 31, 2024 | 595.00 Mn |
| Dec 31, 2023 | 698.00 Mn |
| Sep 30, 2023 | 679.00 Mn |
| Jun 30, 2023 | 703.00 Mn |
| Mar 31, 2023 | 641.00 Mn |
| Dec 31, 2022 | 671.00 Mn |
| Sep 30, 2022 | 561.00 Mn |
| Jun 30, 2022 | 563.00 Mn |
| Mar 31, 2022 | 581.00 Mn |
| Dec 31, 2021 | 649.00 Mn |
| Sep 30, 2021 | 656.00 Mn |